APPLY NOW Apply NowVirtual Tour VIRTUAL TOUR

Achievements

Dean's Honour List


SUCCESSFULLY PUBLISHED AN IMPACTFUL ARTICLE

Associate Professor Ts Dr Lee Ming Tatt |  Faculty of Pharmaceutical Sciences

Congratulations to Associate Professor Ts Dr Lee Ming Tatt for successfully publishing an impactful article titled "Median nerve stimulation as a non-pharmacological approach to bypass analgesis tolerance to morphone : A proof-of-concept study in mice" in The Journal of Pain (JCR impact Factor 2020 = 5.820, JCR Q1, Clinical Neurology.


SUCCESSFULLY PUBLISHED AN IMPACTFUL ARTICLE

Assistant Professor Dr Ravishankar Ram Mani |  Faculty of Pharmaceutical Sciences

Congratulations to Assistant Professor Dr Ravishankar Ram Mani for successfully publishing an impactful article titled “A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis”, in Cancers (Q1, IF 6.639).


SUCCESSFULLY PUBLISHED AN IMPACTFUL ARTICLE

Associate Professor Ts Dr Lee Ming Tatt |  Faculty of Pharmaceutical Sciences

Congratulations to Associate Professor Ts Dr Lee Ming Tatt for successfully publishing an impactful article titled "α6GABA A Receptor Positive Modulators Alleviate Migraine-like Grimaces in Mice via Compensating GABAergic Deficits in Trigeminal Ganglia"  in Neurotherapeutics (JCR Impact Factor 2020 = 7.62, top 15% in Pharmacology & Pharmacy).


RECIPIENTS OF THE FUNDAMENTAL RESEARCH GRANT SCHEME (FRGS) FROM THE MINISTRY OF EDUCATION

Seven researchers from Faculty of Pharmaceutical Sciences |  Faculty of Pharmaceutical Sciences

Congratulations seven researchers from Faculty of Pharmaceutical Sciences in receiving FRGS from Ministry of Education Malaysia (MOE) amounting RM888,722 in FRGS I/2021   


Assistant Professor Dr Anand Gaurav

SUCCESSFULLY PUBLISHED AN IMPACTFUL ARTICLE

Assistant Professor Dr. Anand Gaurav |  Faculty of Pharmaceutical Sciences

Congratulations to Assistant Professor Dr Anand Gaurav for his latest 2021 publication in Journal of Molecular Liquids [JCR Impact Factor 2020 = 6.165, top 10% (Scopus) in Condensed Matter Physics, Materials Chemistry and Spectroscopy categories], titled: “Identification of Dual Inhibitor of Phosphodiesterase 1B/10A using Structure-Based Drug Design Approach”.


EDITORIAL APPOINTMENT FOR DR JUNAID

Assistant Professor Dr Muhammad Junaid Farrukh |  Faculty of Pharmaceutical Sciences

Dr Junaid was appointed as an Academic Editor of the PLOS ONE Editorial Board.


MPS NATIONAL PHARMACISTS CONVENTION 2021 COMMITTEE

Associate Professor Dr Mogana Sundari Rajagopal |  Faculty of Pharmaceutical Sciences

Scientific Committee Chair:

Associate Professor Dr Mogana Sundari Rajagopal

Committee members:

  1. Assistant Professor Dr Muhammad Junaid Farrukh,
  2. Por Choo Shiuan
  3. Annabelle Rose Joykin
  4. Hee Mei Qi
  5. Yap Chuan Sheng

The team from the Faculty of Pharmaceutical Sciences were selected to be part of the Prestigious MPS National Pharmacists Convention 2021 Committee.


DOUBLE APPOINTMENT FOR DR MOGANA

Associate Professor Dr Mogana Sundari Rajagopal |  Faculty of Pharmaceutical Sciences

Prof Dr Mogana was appointed as a Council Member of the Malaysian Pharmacists Society for the 2021 – 2023 term. She was also appointed as an editor of the Malaysian Journal of Pharmacy.


SILVER MEDALIST OF THE 31ST INTERNATIONAL INVENTION, INNOVATION, AND TECHNOLOGY EXHIBITION MALAYSIA

Associate Professor Dr Mogana Sundari Rajagopal |  Faculty of Pharmaceutical Sciences

Won the silver medal award for their product entry at the 31st International Invention, Innovation, and Technology 2020. Their product, TomoClear, is an anti-pigmentation cream which incorporates tomato seeds.


SILVER MEDALIST OF THE 31ST INTERNATIONAL INVENTION, INNOVATION, AND TECHNOLOGY EXHIBITION MALAYSIA

ASSOCIATE PROFESSOR DR. PALANIRAJAN VIJAYARAJ KUMAR |  Faculty of Pharmaceutical Sciences

And his team won the silver medal award for their product entry at the 31st International Invention, Innovation, and Technology 2020. Their product is Kollicoat MAE 100P Coated Capsules to Deliver the Cyclodextrin-Everolimus Inclusive Complex to Treat Colorectal Cancer.


Want to know more? Contact us today to find out more.